Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis
Crossref DOI link: https://doi.org/10.1186/s12964-015-0103-0
Published Online: 2015-04-29
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Philipp, Stephan
Sosna, Justyna
Plenge, Johannes
Kalthoff, Holger
Adam, Dieter
License valid from 2015-04-29
Article History
Received: 18 November 2014
Accepted: 17 April 2015
First Online: 29 April 2015